Literature DB >> 27023104

Catastrophic antiphospholipid syndrome in pregnancy, a diagnosis that should not be missed.

Jennifer G Hoayek1, Hind N Moussa1, Hina A Rehman1, Susan Hosseini Nasab1, Sean C Blackwell1, Baha M Sibai1.   

Abstract

Catastrophic antiphospholipid syndrome (CAPS) is an accelerated form of the antiphospholipid antibody syndrome resulting in multi-organ ischemia and failure. It is a rare and life-threatening condition that can be easily mistaken with hemolysis elevated liver enzymes low platelets syndrome, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. In order to make a diagnosis, it is required to have multi-organ thrombosis over 1 week affecting at least three organs or systems, and to have positive antiphospholipid antibody on two occasions (6 weeks apart), and histopathologic confirmation of small vessel occlusion. However, due to similarities in clinical and laboratory findings between CAPS and some other obstetric complications, potential misdiagnosis or delay in diagnosis are common, increasing the risk of adverse maternal and perinatal outcomes. In this review we summarized information presented in previous studies, focusing on CAPS related to pregnancy. We reviewed diagnostic criteria, differential diagnosis, and common presentation ranging from malaise, abdominal pain, dyspnea, hypertension, to altered mental status and seizures. We also discussed management in pregnancy and included a detailed algorithm with steps to take. Of note, the most significant reduction in mortality was seen in patients receiving triple therapy which will be discussed in this review.

Entities:  

Keywords:  AFLP; HELLP; antiphospholipid antibody; antiphospholipid syndrome; imitators of preeclampsia; organ thrombosis

Mesh:

Year:  2016        PMID: 27023104     DOI: 10.3109/14767058.2016.1160047

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  3 in total

1.  Clinical Report of Probable Catastrophic Antiphospholipid Syndrome in Pregnancy.

Authors:  Eryk Hakman; Sasha Mikhael
Journal:  Case Rep Obstet Gynecol       Date:  2018-04-03

2.  Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome: A case report.

Authors:  Patrizia Rovere-Querini; Valentina Canti; Roberta Erra; Esperia Bianchi; Giorgio Slaviero; Armando D'Angelo; Susanna Rosa; Massimo Candiani; Maria Teresa Castiglioni
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

Review 3.  Catastrophic antiphospholipid syndrome during pregnancy.

Authors:  Marta Fuentes Carrasco; Alejandra Mayoral Triana; Ignacio Cristóbal Cristóbal García; Noelia Pérez Pérez; Nuria Izquierdo Méndez; Patricia Soler Ruiz; Virginia González González
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2021-07-07       Impact factor: 2.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.